Breast cancer in European Union: An update of screening programmes as of March 2014 (Review)

International Journal of Oncology

Volumn 45, Issue 5, 2014, Pages 1785-1792

  Altobelli, E ^a,b   Lattanzi, A ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b AUSL 4   (Italy)

Author keywords

Breast; Cancer; EU28; Screening

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; EARLY DIAGNOSIS; EUROPEAN UNION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; MEDICAL EDUCATION; MEDICAL INFORMATION; POPULATION RESEARCH; PUBLIC HEALTH SERVICE; REVIEW; BREAST NEOPLASMS; ECONOMICS; FEMALE; PATHOLOGY; UTERINE CERVICAL NEOPLASMS;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN UNION; FEMALE; HEALTH CARE COSTS; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 84907219559     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2632     Document Type: Review

References (76)

1. Althuis MD, Dozier JM, Anderson WF, Devesa SS and Brinton LA: Alobal trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34: 405-412, 2005.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Hortobagyi GN, de la Salazar GJ, Pritchard K, et al: The global breast cancer burden: Variations in epidemiology and survival. Clin Breast Cancer 6: 391-401, 2005.
4. Forbes JF: The incidence of breast cancer: The global burden, public health considerations. Semin Oncol 24 (Suppl 1): S1-20-S1-35, 1997.
5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM (eds): GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. IARC Cancerbase No, 10. International Agency for Research on Cancer, Lyon, 2010.
6. Khatib OMN (ed): Guidelines for the Early Detection and Screening of Breast Cancer. EMRO Technical Publications Series, 30. WHO World Health Organization, Cairo, 2006.
7. Autier P1, Boniol M, La Vecchia C, Vatten L, Gavin A, Héry C and Heanue M: Disparities in breast cancer mortality trends between 30 European countries: Retrospective trend analysis of WHO mortality database. BMJ 341: C3620, 2010.
8. Bosetti C, Bertuccio P, Malvezzi M, et al: Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 24: 2657-2671, 2013.
9. Levi F, Bosetti C, Lucchini F, Negri E and La Vecchia C: Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 14: 497-502, 2005.
10. Tyczynski JE, Plesko I, Aareleid T, et al: Breast cancer mortality patterns and time trends in 10 new EU member states: Mortality declining in young women, but still increasing in the elderly. Int J Cancer 112: 1056-1064, 2004.
11. Botha JL, Bray F, Sankila R and Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39: 1718-1729, 2003.
12. Autier P, Boniol M, Gavin A and Vatten LJ: Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: Trend analysis of WHO mortality database. BMJ 343: D4411, 2011.
13. Fielder HM, Warwick J, Brook D, et al: A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11: 194-198, 2004.
14. Allgood PC, Warwick J, Warren RM, Day NE and Duffy SW: A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98: 206-209, 2008.
15. Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurdsson K and Duffy SW: A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48: 948-955, 2007.
16. Puliti D, Miccinesi G, Collina N, et al: Effectiveness of service screening: A case control study to assess breast cancer mortality reduction. Br J Cancer 99: 423-427, 2008.
17. Roder D, Houssami N, Farshid G, et al: Population screening and intensity of screening are associated with reduced breast cancer mortality: Evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 108: 409-416, 2008.
18. Paap E, Holland R, den Heeten GJ, et al: A remarkable reduction of breast cancer deaths in screened versus unscreened women: A case-referent study. Cancer Causes Control 21: 1569-1573, 2010.
19. Puliti D and Zappa M: Breast cancer screening: Are we seeing the benefit? BMC Med 10: 106, 2012.
20. L 327/34 Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Official Journal of the European Union. European Union, Brussels, L327/34-L327/37, 16.12.2003.
21. Vainio H and Bianchini F (eds): IARC Handbooks of Cancer Prevention. Volume 7. Breast Cancer Screening. IARC Press, International Agency for Research on Cancer, Lyon, 2002.
22. Njor S, Nyström L, Moss S, et al: Breast cancer mortality in mammographic screening in Europe: A review of incidencebased mortality studies. J Med Screen 19 (Suppl 1): S33-S41, 2012.
23. International Cancer Screening Network: Atlanta. Breast Cancer Screening Programs in 26 ICSN Countries, 2012: Organization, Policies, and Program Reach. http://appliedresearch.cancer.gov/icsn/breast/screening.html. Accessed Nov 23, 2013.
24. Broeders M, Moss S, Nyström L, et al: The impact of mammographic screening on breast cancer mortality in Europe: A review of observational studies. J Med Screen 19 (Suppl 1): 14-25, 2012.
25. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG and Wilcox M: The benefits and harms of breast cancer screening: An independent review. Lancet 380: 1778-1786, 2012.
26. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG and Wilcox M: The benefits and harms of breast cancer screening: An independent review. Br J Cancer 108: 2205-2240, 2013.
27. Foca F, Mancini S, Bucchi L, et al: Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer 119: 2022-2028, 2013.
28. Timmers JM, den Heeten GJ, Adang EM, Otten JD, Verbeek AL and Broeders MJ: Dutch digital breast cancer screening: Implications for breast cancer care. Eur J Public Health 22: 925-929, 2012.
29. Houssami N, Lord SJ and Ciatto S: Breast cancer screening: Emerging role of new imaging techniques as adjuncts to mammography. Med J Aust 190: 493-497, 2009.
30. Beemsterboer PM, de Koning HJ, Warmerdam PG, et al: Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer 58: 623-628, 1994.
31. De Koning H: Breast cancer screening; cost-effective in practice? Eur J Radiol 33: 32-37, 2000.
32. Hakama M, Pukkala E, Heikkilä M and Kallio M: Effectiveness of the public health policy for breast cancer screening in Finland: Population based cohort study. BMJ 314: 864-867, 1997.
33. Hakama M, Pukkala E, Söderman B and Day N: Implementation of screening as a public health policy: Issues in design and evaluation. J Med Screen 6: 209-216, 1999.
34. Vutuc C, Waldhoer T and Haidinger G: Breast cancer trends: Opportunistic screening in Austria versus controlled screening in Finland and Sweden. Eur J Cancer Prev 15: 343-346, 2006.
35. Oberaigner W, Daniaux M, Geiger-Gritsch S, Knapp R, Siebert U and Buchberger W: Introduction of organised mammography screening in Tyrol: Results following first year of complete rollout. BMC Public Health 11: 673, 2011.
36. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 49: 1374-1403, 2013.
37. Verleye L, Desomer A, Gailly J and Robays J: Dépistage du cancer du sein: Comment identifier les femmes exposées à un risque accru -Quelles techniques d'imagerie utiliser? Good Clinical Practice (GCP). (ed) Bruxelles: Centre fédéral d'expertise des soins de santé (KCE). KCE Reports 172B. D/2011/10.273/91, 2011.
38. Hermesse J: Résultats de 6 ans de dépistag eorganisé du cancer du sein en Belgique. [Internet] Communiqué par l'Agence intermutualiste. Education Santé, no 261, november 2010. Pag. 5-6. http://www.educationsante.be/es/imprarticle.php?id=1309. Accessed Oct 18, 2013.
39. Center for Protection of Rights in Health Care (CZPZ) Sophia (Bulgary): Screening examinations for breast cancer. http://www.czpz.org/index.php?option=com-content&view=category&id=5 0&Itemid=107&lang=en. Accessed Nov 24, 2013.
40. Tesic V, Kolaric B, Znaor A, Kuna SK and Brkljacic B: Mammographic density and estimation of breast cancer risk in intermediate risk population. Breast J 19: 71-78, 2013.
41. Kelava I, Tomicic K, Kokic M, et al: Breast and gynecological cancers in Croatia, 1988-2008. Croat Med J 53: 100-108, 2012.
42. Brnic Z, Blaškovic D, Klasic B, et al: Image quality of mammography in Croatian nationwide screening program: Comparison between various types of facilities. Eur J Radiol 81: E478-e485, 2012.
43. Hadjisavvas A, Loizidou MA, Middleton N, et al: An investigation of breast cancer risk factors in Cyprus: A case control study. BMC Cancer 10: 1-10, 2010.
44. Ministry of Health Cyprus: Cyprus: Breast cancer screening. http://www.moh.gov.cy. Accessed Oct 15, 2013.
45. Majek O, Danes J, Skovajsova M, et al: Breast cancer screening in the Czech Republic: Time trends in performance indicators during the first seven years of the organised programme. BMC Public Health 11: 288, 2011.
46. Eurostat Breast Cancer: Eurostat screening statistics. http://epp.eurostat.ec.europa.eu/statistics-explained/index.php/Breast-cancer-screening-statistics. Accessed 25 Oct, 2013.
47. Domingo L, Jacobsen KK, von Euler-Chelpin M, et al: Seventeen-years overview of breast cancer inside and outside screening in Denmark. Acta Oncol 52: 48-56, 2013.
48. Jørgensen KJ, Zahl PH and GøtzschePC: Breast cancer mortality in organised mammography screening in Denmark: Comparative study. BMJ 340: C1241, 2010.
49. Matsalu M Ministry of Health Estonia: Crossing borders in breast cancer screening. First International Symposium. October 28 & 29 -2010. Amsterdam. The Netherland. http://www.breastcancerscreening. eu/images/stories/PDF's/101029-05-Presentation-Estonia-Meeli-Matsalu-Symposium-Crossing-borders.pdf. Accessed Sep 17, 2013.
50. Héry C, Ferlay J, Boniol M and AutierP: Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 19: 1187-1194, 2008.
51. Ministry of Health Finland: Breast Cancer screening: Finland. http://www.stm.fi/sosiaali-ja-Yerveyspalvelut/terveyspalvelut/seulonnat. Accessed Oct 16, 2013.
52. Séradour B: Breast cancer screening in France: An overview in 2009. Rev Prat 60: 191-199, 2010 (In French).
53. Biesheuvel C, Weigel S and HeindelW: Mammography screening: Evidence, history and current practice in Germany and other European countries. Breast Care (Basel) 6: 104-109, 2011.
54. Tsakiroglou M, Bakalis M, Valasoulis G, Paschopoulos M, Koliopoulos G and Paraskevaidis E: Women's knowledge and utilization of gynecological cancer prevention services in the Northwest of Greece. Eur J Gynaecol Oncol 32: 178-181, 2011.
55. Boncz I, Sebestyén A, Pintér I, Battyány I and Ember I: The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. J Med Screen 15: 14-17, 2008.
56. Minister for Health and Children Ireland: National Cancer Screening Service. http://www.cancerscreening.ie/. Accessed Mar, 2014.
57. Zorzi M, Fedato C, Grazzini G, et al: Screening for colorectal cancer in Italy, 2010 survey. Epidemiol Prev 36 (Suppl 1): 55-77, 2012.
58. Ministry of Health Latvia: Breast cancer screening. http://www.vmnvd.gov.lv/lv/aktualitates. Accessed Nov 10, 2013.
59. Breast Cancer Screening Germany 11/17/2006: In European-Hospital. http://www.european-hospital.com/en/article/743-Breast-cancer-screening.html. Accessed Oct 12, 2013.
60. Autier P, Shannoun F, Scharpantgen A, et al: A breast cancer screening programme operating in a liberal health care system: The Luxembourg Mammography Programme, 1992-1997. Int J Cancer 97: 828-832, 2002.
61. Shannoun F, Schanck JM, Scharpantgen A, Wagnon MC, Ben Daoud M and Back C: Organisational aspects of mammography screening in digital settings: First experiences of Luxembourg. Radiat Prot Dosimetry 129: 195-198, 2008.
62. Szynglarewicz B, Matkowski R, Kasprzak P, et al: The effectiveness of population-based breast cancer screening programme. Pol Merkur Lekarski 26: 117-120, 2009 (In Polish).
63. Cancer.gov: Atlanta. International Cancer Screening Network. Policies on Number of Views, Double-Reading, and Computer Aided Detection for Breast Cancer Screening Programs in 26 ICSN Countries, 2012. http://appliedresearch.cancer.gov/icsn/breast/policies.reading.html. Accessed Oct 23, 2013.
64. Ministry of Health Portugal: Breast cancer screening. http://www.portaldasaude.pt/portal/conteudos/a+saude+em+portugal/noticias/rastreio+estremoz+14.htm. Accessed Dec 11, 2013.
65. Oncologic Society Romania: Breast cancer screening. http://www.srccjro.org/. Accessed Dec 20, 2013.
66. Dora Project: Breast cancer screening Slovenia. http://www.dpor. si/en/?page-id=97. Accessed Dec 18, 2013.
67. Ascunce N, Salas D, Zubizarreta R, et al: Cancer screening in Spain. Ann Oncol 21 (Suppl 3): Iii43-51, 2010.
68. Pubblic Health England: NHS. Breast cancer screening programme. http://www.cancerscreening.nhs.uk/breastscreen/digital-mammography.html. Accessed Dec 16, 2013.
69. Moser K, Sellars S, Wheaton M, et al: Extending the age range for breast screening in England: Pilot study to assess the feasibility and acceptability of randomization. J Med Screen 18: 96-102, 2011.
70. Buerger H, Otterbach F, Simon R, Schäfer KL, Poremba C and Diallo R: Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189: 521-526, 1999.
71. Buerger H, Schmidt H, Beckmann A, Zänker KS, Boecker W and Brandt B: Genetic characterisation of invasive breast cancer: A comparison of CGH and PCR based multiplex microsatellite analysis. J Clin Pathol 54: 836-840, 2001.
72. Kao J, Salari K, Bocanegra M, et al: Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 4: E6146, 2009.
73. Prat A, Parker JS, Karginova O, et al: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68, 2010.
74. Banegas MP, Tao L, Altekruse S, et al: Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California. Breast Cancer Res Treat 144: 625-634, 2014.
75. Altobelli E, Lattanzi A, Paduano R, Varassi G and di Orio F: Colorectal cancer prevention in Europe: Burden of disease and status of screening programs. Prev Med 62C: 132-141, 2014.
76. James TM, Greiner KA, Ellerbeck EF, Feng C and Ahluwalia JS: Disparities in colorectal cancer screening: A guideline-based analysis of adherence. Ethn Dis 16: 228-233, 2006.